Learn More
ATCC Yellow fever virus, 17D vaccine strain (attenuated) - frozen viral preparation, BSL-2 (ATCC VR-1506)
Supplier: ATCC VR1506
An attenuated Yellow fever virus (17D) vaccine strain supplied as a frozen viral preparation for research and vaccine development. The strain was derived from the Asibi isolate and adapted for propagation in Vero cells; handle under BSL-2 containment.
- Supplied as a frozen viral preparation.
- Store at -70°C or colder.
- Attenuated 17D vaccine strain derived from the Asibi isolate.
- Adapted for propagation in Vero cells (CCL-81).
- Intended for vaccine development and production research.
- Biosafety level 2 containment recommended.
- Geographical origin: Ghana.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.